Changing indications for bone scintigraphy in patients with osteosarcoma
Journal Article
·
· Radiology; (United States)
- Harvard Medical School, Cambridge, MA
Fifty-six patients with osteosarcoma were studied to determine the onset of pulmonary and bone metastases. While pulmonary metastases were always detected prior to bone metastases in the era before adjuvant chemotherapy, in this study of patients on adjuvant therapy 16% of patients with metastases showed osseous metastases prior to or without pulmonary metastases.
- OSTI ID:
- 5151494
- Journal Information:
- Radiology; (United States), Journal Name: Radiology; (United States) Vol. 135:1; ISSN RADLA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Fluorine-18 bone scintigraphy in children with osteosarcoma or Ewing's sarcoma
Indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients
Indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients
Journal Article
·
Fri Nov 30 23:00:00 EST 1973
· Radiology, v. 109, no. 3, pp. 627-632
·
OSTI ID:4406737
Indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients
Journal Article
·
Tue Sep 01 00:00:00 EDT 1981
· Cancer (Philadelphia); (United States)
·
OSTI ID:5309867
Indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients
Journal Article
·
Tue Sep 01 00:00:00 EDT 1981
· Cancer; (United States)
·
OSTI ID:6289504
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIMETABOLITES
ANTIMITOTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CHEMOTHERAPY
COUNTING TECHNIQUES
DATA
DATA FORMS
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ESTERS
EXPERIMENTAL DATA
FLUORINE 18
FLUORINE ISOTOPES
GRAPHS
HOURS LIVING RADIOISOTOPES
INFORMATION
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
METASTASES
METHOTREXATE
NEOPLASMS
NUCLEI
NUMERICAL DATA
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC PHOSPHORUS COMPOUNDS
ORGANS
OSTEOSARCOMAS
PATIENTS
PHOSPHONIC ACID ESTERS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SARCOMAS
SCINTISCANNING
SKELETAL DISEASES
SKELETON
SURVIVAL CURVES
TABLES
TECHNETIUM 99
TECHNETIUM ISOTOPES
THERAPY
TIME DEPENDENCE
YEARS LIVING RADIOISOTOPES
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIMETABOLITES
ANTIMITOTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CHEMOTHERAPY
COUNTING TECHNIQUES
DATA
DATA FORMS
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ESTERS
EXPERIMENTAL DATA
FLUORINE 18
FLUORINE ISOTOPES
GRAPHS
HOURS LIVING RADIOISOTOPES
INFORMATION
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
METASTASES
METHOTREXATE
NEOPLASMS
NUCLEI
NUMERICAL DATA
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC PHOSPHORUS COMPOUNDS
ORGANS
OSTEOSARCOMAS
PATIENTS
PHOSPHONIC ACID ESTERS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SARCOMAS
SCINTISCANNING
SKELETAL DISEASES
SKELETON
SURVIVAL CURVES
TABLES
TECHNETIUM 99
TECHNETIUM ISOTOPES
THERAPY
TIME DEPENDENCE
YEARS LIVING RADIOISOTOPES